IL104124A - Imidazoylalkyl is converted by a hexagonal heterocyclic ring containing nitrogen in their preparation and pharmaceutical preparations containing them - Google Patents

Imidazoylalkyl is converted by a hexagonal heterocyclic ring containing nitrogen in their preparation and pharmaceutical preparations containing them

Info

Publication number
IL104124A
IL104124A IL10412492A IL10412492A IL104124A IL 104124 A IL104124 A IL 104124A IL 10412492 A IL10412492 A IL 10412492A IL 10412492 A IL10412492 A IL 10412492A IL 104124 A IL104124 A IL 104124A
Authority
IL
Israel
Prior art keywords
compound
group
temperature
alkyl
organic solvent
Prior art date
Application number
IL10412492A
Other languages
English (en)
Hebrew (he)
Other versions
IL104124A0 (en
Inventor
Neng-Yang Shih
Michael J Green
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL104124A0 publication Critical patent/IL104124A0/xx
Publication of IL104124A publication Critical patent/IL104124A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
IL10412492A 1991-12-18 1992-12-17 Imidazoylalkyl is converted by a hexagonal heterocyclic ring containing nitrogen in their preparation and pharmaceutical preparations containing them IL104124A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81065191A 1991-12-18 1991-12-18

Publications (2)

Publication Number Publication Date
IL104124A0 IL104124A0 (en) 1993-05-13
IL104124A true IL104124A (en) 1998-12-06

Family

ID=25204344

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10412492A IL104124A (en) 1991-12-18 1992-12-17 Imidazoylalkyl is converted by a hexagonal heterocyclic ring containing nitrogen in their preparation and pharmaceutical preparations containing them

Country Status (19)

Country Link
EP (1) EP0619818B1 (zh)
JP (1) JPH07121938B2 (zh)
KR (1) KR0142801B1 (zh)
AT (1) ATE140223T1 (zh)
AU (1) AU665604B2 (zh)
CA (1) CA2126086C (zh)
DE (1) DE69212164T2 (zh)
DK (1) DK0619818T3 (zh)
ES (1) ES2089782T3 (zh)
GR (1) GR3021195T3 (zh)
HK (1) HK31097A (zh)
IL (1) IL104124A (zh)
MX (1) MX9207392A (zh)
MY (1) MY108904A (zh)
NZ (1) NZ246434A (zh)
SG (1) SG44565A1 (zh)
TW (1) TW263503B (zh)
WO (1) WO1993012107A1 (zh)
ZA (1) ZA929785B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006037A1 (en) * 1993-08-27 1995-03-02 Vrije Universiteit New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor
NL9302045A (nl) * 1993-08-27 1995-03-16 Vrije Universiteit Nieuwe imidazoolafgeleide met agonistische of antagonistische activiteit op de histamine H3-receptor.
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
EP0862435A4 (en) * 1995-11-22 1999-02-03 Merck & Co Inc INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
CA2250353A1 (en) * 1996-04-03 1997-10-09 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
US6072057A (en) * 1996-06-06 2000-06-06 Gliatech Inc. 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor agents
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
HUP0102662A3 (en) * 1997-11-07 2003-01-28 Schering Corp Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
RU2235092C2 (ru) * 1997-12-04 2004-08-27 Оллерган Инк. Замещенные производные имидазола, способ введения активного соединения и способ лечения на основе этих соединений
US6133291A (en) * 1998-10-16 2000-10-17 Schering Corporation N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
AU3033100A (en) 1999-01-18 2000-08-01 Boehringer Ingelheim International Gmbh Substituted imidazoles, their preparation and use
US6211182B1 (en) * 1999-03-08 2001-04-03 Schering Corporation Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
EP1313470A4 (en) 2000-08-17 2005-02-16 Gliatech Inc NEW ALICYCLIC IMIDAZOLE AS H 3 ACTIVE SUBSTANCES
WO2003070722A1 (fr) 2002-02-21 2003-08-28 Azwell Inc. Amelioration apportee a la production de derives d'imidazole et de nouveaux intermediaires de ces derives
EP1707203A1 (en) 2005-04-01 2006-10-04 Bioprojet Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
EP1717235A3 (en) 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
EP1717233A1 (en) 2005-04-29 2006-11-02 Bioprojet Histamine H3-receptor ligands and their therapeutic application
NZ575624A (en) 2006-10-18 2012-02-24 Pfizer Prod Inc Biaryl ether urea compounds
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2586562B1 (fr) * 1985-09-02 1989-03-10 Inst Nat Sante Rech Med Composition pharmaceutique contenant de l'a-methylhistamine
EP0372125A1 (en) * 1988-11-08 1990-06-13 Akzo N.V. Oxazole and thiazole derivatives
US4925851A (en) * 1989-05-23 1990-05-15 Sandoz Pharmaceuticals Corp. 2- or 4-substituted-[2-(1H-imidazol-1-yl)ethyl]piperidines

Also Published As

Publication number Publication date
KR940703827A (zh) 1994-12-12
AU3275893A (en) 1993-07-19
WO1993012107A1 (en) 1993-06-24
ZA929785B (en) 1993-06-21
CA2126086A1 (en) 1993-06-24
DK0619818T3 (da) 1996-11-25
JPH06511252A (ja) 1994-12-15
CA2126086C (en) 2000-03-28
KR0142801B1 (en) 1998-07-15
DE69212164D1 (de) 1996-08-14
AU665604B2 (en) 1996-01-11
EP0619818B1 (en) 1996-07-10
MY108904A (en) 1996-11-30
EP0619818A1 (en) 1994-10-19
GR3021195T3 (en) 1996-12-31
DE69212164T2 (de) 1996-12-05
SG44565A1 (en) 1997-12-19
ATE140223T1 (de) 1996-07-15
NZ246434A (en) 1996-02-27
TW263503B (zh) 1995-11-21
JPH07121938B2 (ja) 1995-12-25
MX9207392A (es) 1993-06-01
ES2089782T3 (es) 1996-10-01
IL104124A0 (en) 1993-05-13
HK31097A (en) 1997-03-21

Similar Documents

Publication Publication Date Title
IL104124A (en) Imidazoylalkyl is converted by a hexagonal heterocyclic ring containing nitrogen in their preparation and pharmaceutical preparations containing them
EP0618913B1 (en) Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
AU662588B2 (en) Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine H3 agonists/antagonists
US5578612A (en) Indole derivatives
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
US5607951A (en) Indole derivatives
WO1992005172A2 (en) Muscarinic receptor antagonists
CZ282652B6 (cs) Indolové deriváty, způsob jejich přípravy, meziprodukty tohoto postupu, farmaceutické prostředky obsahující tyto deriváty a použití těchto derivátů
US5559129A (en) Indole derivatives
US5807872A (en) Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
US5559246A (en) Indole derivatives
US5607957A (en) Imidazole, triazole and tetrazole derivatives
WO1999024421A1 (en) Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
EP0733049A1 (en) Tricyclic derivatives and their use in pharmaceuticals
US5932596A (en) Imidazoylalkyl substituted with a six membered nitrogen containing nitrogen containing heterocyclic ring
US5633250A (en) Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
US5773448A (en) Pharmaceutical compounds
KR20110097996A (ko) 에탄아민 화합물 및 우울증의 치료를 위한 그의 용도
MXPA00004399A (en) Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force